{"text": ["Lilly's", "Olumiant", "Succeeds", "in", "Another", "Late-Stage", "Eczema", "Study"], "created_at": "2020-01-31 21:53:09"}
{"text": ["Earnings", "Miss:", "Pfizer", "Inc.", "Missed", "EPS", "By", "16%", "And", "Analysts", "Are", "Revising", "Their", "Forecasts"], "created_at": "2020-01-31 15:41:08"}
{"text": ["Pharma", "Stock", "Roundup:", "LLY,", "PFE", "Q4", "Results,", "JNJ's", "Coronavirus", "Vaccine", "Initiative"], "created_at": "2020-01-31 15:32:18"}
{"text": ["Bayer", "Seeks", "FDA", "Approval", "for", "New", "Formulation", "of", "Nifurtimox"], "created_at": "2020-01-31 15:15:33"}
{"text": ["Pfizer", "Receives", "Positive", "CHMP", "Opinion", "for", "Oncology", "Biosimilar,", "RUXIENCE\u2122", "(rituximab)"], "created_at": "2020-01-31 14:00:00"}
{"text": ["Bayer", "wins", "EU", "recommendation", "for", "prostate", "cancer", "drug"], "created_at": "2020-01-31 12:30:06"}
